In patients with cardiovascular disease who had an ICD and were at high risk for ventricular arrhythmias, increasing potassium levels led to a significantly lower risk for arrhythmia events.
A new algorithm, tested via computer modeling across the continental United States, more accurately routes patients with stroke to EVT centers, boosting functional outcomes.
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a practice-changing trial, according to experts.
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to show a benefit in three new randomized trials.
For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring results from SPRINT in patients without diabetes.